Advertisement
Clinical MedicineIn-Press PreviewGastroenterology Open Access | 10.1172/JCI184785
1Department of Medicine, Mayo Clinic, Scottsdale, United States of America
2Department of Clinical Trials and Biostatistics, Mayo Cinic, Scottsdale, United States of America
3Department of Medicine, Mayo Cinic, Scottsdale, United States of America
4Department of Laboratory Medicine and Pathology, Mayo Cinic, Scottsdale, United States of America
Find articles by Rajalingamgari, P. in: JCI | PubMed | Google Scholar
1Department of Medicine, Mayo Clinic, Scottsdale, United States of America
2Department of Clinical Trials and Biostatistics, Mayo Cinic, Scottsdale, United States of America
3Department of Medicine, Mayo Cinic, Scottsdale, United States of America
4Department of Laboratory Medicine and Pathology, Mayo Cinic, Scottsdale, United States of America
Find articles by Khatua, B. in: JCI | PubMed | Google Scholar |
1Department of Medicine, Mayo Clinic, Scottsdale, United States of America
2Department of Clinical Trials and Biostatistics, Mayo Cinic, Scottsdale, United States of America
3Department of Medicine, Mayo Cinic, Scottsdale, United States of America
4Department of Laboratory Medicine and Pathology, Mayo Cinic, Scottsdale, United States of America
Find articles by Summers, M. in: JCI | PubMed | Google Scholar
1Department of Medicine, Mayo Clinic, Scottsdale, United States of America
2Department of Clinical Trials and Biostatistics, Mayo Cinic, Scottsdale, United States of America
3Department of Medicine, Mayo Cinic, Scottsdale, United States of America
4Department of Laboratory Medicine and Pathology, Mayo Cinic, Scottsdale, United States of America
Find articles by Kostenko, S. in: JCI | PubMed | Google Scholar
1Department of Medicine, Mayo Clinic, Scottsdale, United States of America
2Department of Clinical Trials and Biostatistics, Mayo Cinic, Scottsdale, United States of America
3Department of Medicine, Mayo Cinic, Scottsdale, United States of America
4Department of Laboratory Medicine and Pathology, Mayo Cinic, Scottsdale, United States of America
Find articles by Chang, Y. in: JCI | PubMed | Google Scholar
1Department of Medicine, Mayo Clinic, Scottsdale, United States of America
2Department of Clinical Trials and Biostatistics, Mayo Cinic, Scottsdale, United States of America
3Department of Medicine, Mayo Cinic, Scottsdale, United States of America
4Department of Laboratory Medicine and Pathology, Mayo Cinic, Scottsdale, United States of America
Find articles by Elmallahy, M. in: JCI | PubMed | Google Scholar
1Department of Medicine, Mayo Clinic, Scottsdale, United States of America
2Department of Clinical Trials and Biostatistics, Mayo Cinic, Scottsdale, United States of America
3Department of Medicine, Mayo Cinic, Scottsdale, United States of America
4Department of Laboratory Medicine and Pathology, Mayo Cinic, Scottsdale, United States of America
Find articles by Anand, A. in: JCI | PubMed | Google Scholar
1Department of Medicine, Mayo Clinic, Scottsdale, United States of America
2Department of Clinical Trials and Biostatistics, Mayo Cinic, Scottsdale, United States of America
3Department of Medicine, Mayo Cinic, Scottsdale, United States of America
4Department of Laboratory Medicine and Pathology, Mayo Cinic, Scottsdale, United States of America
Find articles by Narayana Pillai, A. in: JCI | PubMed | Google Scholar
1Department of Medicine, Mayo Clinic, Scottsdale, United States of America
2Department of Clinical Trials and Biostatistics, Mayo Cinic, Scottsdale, United States of America
3Department of Medicine, Mayo Cinic, Scottsdale, United States of America
4Department of Laboratory Medicine and Pathology, Mayo Cinic, Scottsdale, United States of America
Find articles by Morsy, M. in: JCI | PubMed | Google Scholar
1Department of Medicine, Mayo Clinic, Scottsdale, United States of America
2Department of Clinical Trials and Biostatistics, Mayo Cinic, Scottsdale, United States of America
3Department of Medicine, Mayo Cinic, Scottsdale, United States of America
4Department of Laboratory Medicine and Pathology, Mayo Cinic, Scottsdale, United States of America
Find articles by Trivedi, S. in: JCI | PubMed | Google Scholar |
1Department of Medicine, Mayo Clinic, Scottsdale, United States of America
2Department of Clinical Trials and Biostatistics, Mayo Cinic, Scottsdale, United States of America
3Department of Medicine, Mayo Cinic, Scottsdale, United States of America
4Department of Laboratory Medicine and Pathology, Mayo Cinic, Scottsdale, United States of America
Find articles by McFayden, B. in: JCI | PubMed | Google Scholar |
1Department of Medicine, Mayo Clinic, Scottsdale, United States of America
2Department of Clinical Trials and Biostatistics, Mayo Cinic, Scottsdale, United States of America
3Department of Medicine, Mayo Cinic, Scottsdale, United States of America
4Department of Laboratory Medicine and Pathology, Mayo Cinic, Scottsdale, United States of America
Find articles by Jahangir, S. in: JCI | PubMed | Google Scholar
1Department of Medicine, Mayo Clinic, Scottsdale, United States of America
2Department of Clinical Trials and Biostatistics, Mayo Cinic, Scottsdale, United States of America
3Department of Medicine, Mayo Cinic, Scottsdale, United States of America
4Department of Laboratory Medicine and Pathology, Mayo Cinic, Scottsdale, United States of America
Find articles by Snozek, C. in: JCI | PubMed | Google Scholar
1Department of Medicine, Mayo Clinic, Scottsdale, United States of America
2Department of Clinical Trials and Biostatistics, Mayo Cinic, Scottsdale, United States of America
3Department of Medicine, Mayo Cinic, Scottsdale, United States of America
4Department of Laboratory Medicine and Pathology, Mayo Cinic, Scottsdale, United States of America
Find articles by Singh, V. in: JCI | PubMed | Google Scholar
Published November 7, 2024 - More info
Background: While most hypertriglyceridemia is asymptomatic, hypertriglyceridemia-associated acute pancreatitis (HTG-AP) can be more severe than other AP etiologies. The reasons underlying this are unclear. We thus studied whether lipolytic generation of non-esterified fatty acids (NEFA) from circulating triglycerides (TGs) could worsen clinical outcomes. Methods: Admission serum TGs, NEFA compositions and concentrations were analyzed prospectively in 269 patients with AP. These and demographics, clinical outcomes were compared between HTGAP (TGs >500mg/dL; American Heart Association 2018 guidelines) and other AP etiologies. Serum NEFAs were correlated with the serum triglyceride fatty acids (TGFAs) alone, and with the product of TGFA x serum lipase (NEFA-TGFA x lipase). Studies in mice, rats were done to understand the role of HTG lipolysis in organ failure and to interpret the NEFA-TGFA correlations. Results: HTG-AP patients had higher serum NEFAs and TGs and more severe AP (19% vs. 7% p<0.03) than other etiologies. Correlations of long-chain unsaturated NEFA with corresponding TGFAs increased with TG concentrations up to 500mg/dL and declined thereafter. However, NEFA-TGFA x lipase correlations got stronger with TGs >500mg/dL. AP, and intravenous lipase infusion in rodents caused lipolysis of circulating TGs to NEFA. This led to multi-system organ failure, which was prevented by pancreatic triglyceride lipase deletion, or lipase inhibition. Conclusions: HTG-AP is made severe by the NEFAs generated form intravascular lipolysis of circulating TGs. Strategies that prevent TG lipolysis may be effective in improving clinical outcomes of HTG-AP. Trial registration: Not applicable. Funding: This project was supported by Grant numbers RO1DK092460, R01DK119646 from the NIDDK, PR191945 under W81XWH-20-1-0400 from the DOD (VPS), and R01AA031257 from the NIAAA (VPS).